Podcast
MSL Talk, Tom Caravela, Josh Yoder, Kirsten Borbe
Filler Words Fix the Problem You Didn't Know You Had
Summary
In this episode, Tom Caravela delves into the significance of eliminating filler words in professional as well as personal communication. He highlights the impact of these verbal fillers on perceived competence and interview performance, supported by revealing statistics. Tom explores the demographic differences in the use of filler words and their effects on audience engagement. He provides practical strategies for reducing filler words, emphasizing the importance of preparation, practice, and the power of slowing down and pausing. The episode concludes with insights on mindfulness and self-awareness in speech, encouraging listeners to refine their communication skills for enhanced professional presence.
Key Points
- Eliminating filler words can significantly enhance your professional image, making you appear more confident and competent.
- Preparation and practice are key to eliminating the need to fill gaps with habitual words.
- Slowing down and embracing pauses in your speech can improve clarity and engagement, preventing the need for filler words.
filler words, communication skills, professional presence, audience engagement, verbal fillers
Related Topics
You May Also Like
MSL Talk, Tom Caravela, Josh Yoder, Kirsten Borbe
Podcast
MSL Talk: Tom Caravela
Top 5 MSL Frustrations and How to Overcome Them
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Podcast
MSL Talk: Tom Caravela, Josh Corriveau
MSL Career Options: The transition from Field Medical to Medical Director
Article
Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
Article
Sarah A. Weiss, MD, and Harriet Kluger, MD